Additionally, some scholars have identified and validated a novel ferroptosis-related gene signature, consisting of SLC7A11, ZFP36, and TTBK2, as an independent prognostic indicator for predicting the treatment response of ovarian cancer patients (Yang et al., 2023). The gene discussed is SLC7A11; the disease is ovarian carcinoma.